Presenilin-dependent intramembrane cleavage of ephrin-B1
2006; 1: 2
Pathological and physiological functions of presenilins
2006; 1: 4
Zoom in on neurodegeneration
2006; 1: 1
Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel γ-secretase substrates
2006; 1: 3
The amyloid precursor protein: beyond amyloid
2006; 1: 5
Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau
2006; 1: 7
Modulation of β-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family
2006; 1: 8
Las noticias de Madrid (News from Madrid)
2006; 1: 10
Bcl-2 over-expression fails to prevent age-related loss of calretinin positive neurons in the mouse dentate gyrus
2006; 1: 9
Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression
2006; 1: 6
Natural distribution of environmental radon daughters in the different brain areas of an Alzheimer Disease victim
2006; 1: 11
ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients
2006; 1: 13
Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease
2006; 1: 14
Altered hippocampus synaptic function in selenoprotein P deficient mice
2006; 1: 12
The generation and function of soluble apoE receptors in the CNS
2006; 1: 15
Signal peptide peptidase (SPP) dimer formation as assessed by fluorescence lifetime imaging microscopy (FLIM) in intact cells
2006; 1: 16
LRRK2 in Parkinson's disease and dementia with Lewy bodies
2006; 1: 17
Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons
2006; 1: 18
Multiple pathways contribute to the pathogenesis of Huntington disease
2006; 1: 19
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
2007; 2: 1